Quick Answer
BIOGEN INC. reported Total Revenue of $9.89 billion for fiscal year 2025.
BIOGEN INC. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $9.89B | +2.2% |
| 2024 | $9.68B | -1.6% |
| 2023 | $9.84B | -3.3% |
| 2022 | $10.17B | -7.4% |
| 2021 | $10.98B | -18.3% |
| 2020 | $13.44B | -6.5% |
| 2019 | $14.38B | +6.9% |
| 2018 | $13.45B | +9.6% |
| 2017 | $12.27B | +7.2% |
| 2016 | $11.45B | +6.4% |
| 2015 | $10.76B | +10.9% |
| 2014 | $9.70B | +40.0% |
| 2013 | $6.93B | +25.7% |
| 2012 | $5.52B | +9.3% |
| 2011 | $5.05B | +7.0% |
| 2010 | $4.72B | +7.7% |
| 2009 | $4.38B | +6.8% |
| 2008 | $4.10B | +29.2% |
| 2007 | $3.17B | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.53B | +2.8% | -4.2% |
| June 30, 2025 | $2.65B | +7.3% | +8.8% |
| March 31, 2025 | $2.43B | +6.1% | -1.4% |
| September 30, 2024 | $2.47B | -2.5% | +0.0% |
| June 30, 2024 | $2.46B | +0.4% | +7.6% |
| March 31, 2024 | $2.29B | -7.0% | -9.5% |
| September 30, 2023 | $2.53B | +0.9% | +3.0% |
| June 30, 2023 | $2.46B | -5.1% | -0.3% |
- BIOGEN INC. showed an increase of +2.2% in Total Revenue compared to the prior fiscal year.
- Over the 2007–2025 period, BIOGEN INC.’s total revenue has grown by 211.8% (from $3.17 billion to $9.89 billion).
- The most recent figure is from BIOGEN INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: